HRSA proposed rule would establish dispute resolution process for 340B program

AHA News Now

The Health Resources and Services Administration today released a proposed rule that would implement an Affordable Care Act provision requiring a binding administrative dispute resolution process for 340B Drug Pricing Program participants who claim they have been overcharged for drugs purchased through... read more

Topic: Advocacy and Public Policy
Tags: 340B, Drug Pricing Program, regulation

HRSA webinar tomorrow to discuss 340B recertification

AHA News Now

The Health Resources and Services Administration's Office of Pharmacy Affairs will host a webinar July 20 to assist covered entities with the recertification process for the 340B Drug Pricing Program. Hospitals can join the webinar, from 1 p.m. to 2 p.m. ET, by visiting ... read more

Topic: Advocacy and Public Policy
Tag: 340B

AHASTAT Blog: Hospitals and 340B program help preserve, protect the safety-net

AHA News Now

Hospitals, including those participating in the 340B Drug Pricing Program, are the true safety-net, not the pharmaceutical industry with its “skyrocketing prescription drug prices and huge profits,” AHA Executive Vice President Tom Nickels writes in an AHASTAT blog post today. Nickels notes that hospitals... read more

Topic: Advocacy and Public Policy
Tag: 340B

Hospitals, not pharmaceutical manufacturers, are preserving and protecting the safety net

Blog

A group financed by the pharmaceutical industry is hosting a meeting today on the 340B Drug Pricing Program with the goal of “Preserving the True Safety Net.” But what the meeting really will be about is the pharmaceutical industry – with their skyrocketing prescription drug prices and huge profits –... read more

Topic: Access and Coverage
Tags: 340B, Drug Pricing Program, Community benefit, access, drug prices

Senate holds third hearing on recent surge in older drug prices

AHA News Now

The Senate Special Committee on Aging today held the third in a series of hearings to investigate sudden and aggressive price spikes in older prescription drugs. Testifying at the hearing, Richard Fogel, M.D., chief clinical officer for Ascension Health’s St. Vincent health system in Indiana, said... read more

Topic: Advocacy and Public Policy
Tags: 340B, drug prices

AHASTAT blog: Reducing 340B is not the answer to curbing skyrocketing drug prices

AHA News Now

A recent proposal that calls for reducing the benefits of the 340B Drug Pricing Program to curb rapidly rising prescription drug costs is “misguided,” writes AHA Executive Vice President Tom Nickels in an AHASTAT blog post today. Responding to a recent opinion piece in the New England Journal of Medicine,... read more

Topic: Advocacy and Public Policy
Tag: 340B

Changing 340B is the wrong prescription for addressing skyrocketing pharmaceutical costs

Blog

The rapidly rising costs of prescription drugs is causing significant financial challenges for patients and their care providers.

Many groups, including the AHA, are evaluating options for addressing this important issue. However, one recent proposal, which is seriously misguided, would reduce a program... read more

Topic: Access and Coverage
Tags: 340B, Drug Pricing Program, access, price, drug prices

CMS issues final rule for Medicaid drug rebates, reimbursement

AHA News Now

The Centers for Medicare & Medicaid Services yesterday published its long-awaited final rule implementing Affordable Care Act changes to the Medicaid Drug Rebate Program and Medicaid reimbursement for covered outpatient drugs. According to CMS, the rule creates a regulatory definition for Average... read more

Topic: Advocacy and Public Policy
Tags: 340B, Drug Pricing Program, Medicaid, regulation

AHA critical of MedPAC's "misdirected" 340B payment proposal

AHA News

The AHA last week criticized as “misdirected” and a blow to patient care the Medicare Payment Assessment Commission’s (MedPAC) recommendation that Congress reduce Part B drug payment rates to hospitals participating in the 340B Drug Pricing Program.

At its Jan. 14 meeting, the commission voted 14 to 3 to... read more

Topic: Advocacy and Public Policy
Tags: 340B, Drug Pricing Program

MedPAC finalizes 2017 payment recommendations for hospital services

AHA News Now

The Medicare Payment Advisory Commission today recommended that Congress update payments for hospital inpatient and outpatient services in 2017 as outlined under current law, which would provide an estimated 1.65% increase. In addition, MedPAC voted to reduce Part B drug payment rates for hospitals... read more

Topic: Advocacy and Public Policy
Tags: 340B, Medicare

Keyword Search

Date